Synthesis
of
chemically
diverse
heterocyclic
scaffolds
in
DNA-encoded
libraries
is
highly
demanded.
We
herein
reported
a
convenient
one-pot
multi-component
on-DNA
synthetic
strategy
to
afford
multi-substituted
2,3-dihydrofuran
via
pyridinium
ylide-mediated
cyclization.
This
reaction
exhibited
modest
excellent
conversions
for
broad
range
DNA-conjugated
aldehydes,
β-ketonitriles
and
salts
under
mild
conditions.
Furthermore,
the
compatibility
this
with
DEL
construction
was
verified
by
enzymatic
DNA
ligation,
PCR
amplification
mock
library
synthesis.
Angewandte Chemie International Edition,
Journal Year:
2022,
Volume and Issue:
62(9)
Published: Dec. 2, 2022
Abstract
DNA‐encoded
library
(DEL)
technologies
are
transforming
the
drug
discovery
process,
enabling
identification
of
ligands
at
unprecedented
speed
and
scale.
DEL
makes
use
libraries
that
orders
magnitude
larger
than
traditional
high‐throughput
screens.
While
a
DNA
tag
alludes
to
genotype–phenotype
connection
is
exploitable
for
molecular
evolution,
most
work
in
field
performed
with
where
serves
as
an
amplifiable
barcode
but
does
not
allow
“translation”
into
synthetic
product
it
linked
to.
In
this
Review,
we
cover
enable
genetic
molecules,
both
biochemically
chemically,
explore
how
can
be
used
harness
Darwinian
evolutionary
pressure.
Acta Pharmaceutica Sinica B,
Journal Year:
2023,
Volume and Issue:
14(2), P. 492 - 516
Published: Oct. 11, 2023
DNA-encoded
chemical
library
(DEL)
links
the
power
of
amplifiable
genetics
and
non-self-replicating
phenotypes,
generating
a
diverse
world.
In
analogy
with
biological
world,
DEL
world
can
evolve
by
using
central
dogma,
wherein
DNA
replicates
PCR
reactions
to
amplify
genetic
codes,
sequencing
transcripts
information,
DNA-compatible
synthesis
translates
into
phenotypes.
Importantly,
is
key
expanding
space.
Besides,
evolution-driven
selection
system
pushes
chemicals
under
selective
pressure,
i.e.,
desired
strategies.
this
perspective,
we
summarized
recent
advances
in
synthetic
toolbox
panning
strategies,
which
will
shed
light
on
drug
discovery
harnessing
vitro
evolution
via
DEL.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(8), P. 3362 - 3384
Published: April 10, 2024
Drug
discovery
is
a
sophisticated
process
that
incorporates
scientific
innovations
and
cutting-edge
technologies.
Compared
to
traditional
bioactivity-based
screening
methods,
encoding
display
technologies
for
combinatorial
libraries
have
recently
advanced
from
proof-of-principle
experiments
promising
tools
pharmaceutical
hit
due
their
high
efficiency,
throughput,
resource
minimization.
This
review
systematically
summarizes
the
development
history,
typology,
prospective
applications
of
displayed
technologies,
including
phage
display,
ribosomal
mRNA
yeast
cell
one-bead
one-compound,
DNA-encoded,
peptide
nucleic
acid-encoded,
new
peptide-encoded
examples
preclinical
clinical
translation.
We
discuss
progress
novel
targeted
therapeutic
agents,
covering
spectrum
small-molecule
inhibitors
nonpeptidic
macrocycles
linear,
monocyclic,
bicyclic
peptides,
in
addition
antibodies.
also
address
pending
challenges
future
prospects
drug
discovery,
size
libraries,
advantages
disadvantages
technology,
translational
potential,
market
space.
intended
establish
comprehensive
high-throughput
strategy
researchers
developers.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(15)
Published: Feb. 12, 2024
Abstract
Click
chemistry
is
a
powerful
molecular
assembly
strategy
for
rapid
functional
discovery.
The
development
of
click
reactions
with
new
connecting
linkage
great
importance
expanding
the
toolbox.
We
report
first
selenium‐nitrogen
exchange
(SeNEx)
reaction
between
benzoselenazolones
and
terminal
alkynes
(Se−N
to
Se−C),
which
inspired
by
biochemical
SeNEx
Ebselen
cysteine
(Cys)
residue
Se−S).
formed
selenoalkyne
connection
readily
elaborated,
thus
endowing
this
multidimensional
diversity.
Besides,
modular,
predictable,
high‐yielding,
features
fast
kinetics
(k2≥14.43
M
−1
s
),
excellent
group
compatibility,
works
well
at
miniaturization
(nanomole‐scale),
opening
up
many
interesting
opportunities
organo‐Se
synthesis
bioconjugation,
as
exemplified
sequential
(coupled
ruthenium‐catalyzed
azide‐alkyne
cycloaddition
(RuAAC)
sulfur‐fluoride
(SuFEx)),
selenomacrocycle
synthesis,
nanomole‐scale
Se‐containing
natural
product
library
DNA‐encoded
(DEL),
late‐stage
peptide
modification
ligation,
multiple
functionalization
proteins.
These
results
indicated
that
useful
developments,
established
will
serve
transformative
platform
in
multidisciplinary
fields
such
synthetic
chemistry,
material
science,
chemical
biology,
medical
drug
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
53(10), P. 4838 - 4861
Published: Jan. 1, 2024
In
this
review
we
highlight
how
the
synthesis
of
degraders
has
evolved
in
recent
years,
particular
application
high-throughput
chemistry
and
screening
approaches
such
as
D2B
DEL
technologies
to
expedite
discovery
timelines.
Small Methods,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
Abstract
Deoxyribonucleic
acid
(DNA),
a
fundamental
biomacromolecule
in
living
organisms,
serves
as
the
carrier
of
genetic
information.
Beyond
its
role
encoding
biological
functions,
DNA's
inherent
ability
to
hybridize
through
base
pairing
has
opened
new
avenues
for
application
sciences.
This
review
introduces
DNA
nanotechnology
and
DNA‐encoded
library
(DEL),
highlights
their
shared
design
principles
related
assembly.
First,
foundational
overview
structural
nanotechnology,
including
strategies
historical
development
is
provided.
Subsequently,
various
approaches
are
examined
dynamic
from
strand
displacement
reactions
DNA‐templated
polymer
synthesis.
Second,
how
principle
assembly
facilitated
diverse
formats
self‐assembly‐based
DEL
synthesis,
DNA‐template
(DTS),
template‐mediated
proximity
induction
effects
examined.
These
advancements
all
underpinned
by
unique
property
Finally,
this
summarizes
common
terms
methodology
design.
Additionally,
potential
synergies
explored
between
these
two
technologies,
envisioning
future
applications
where
they
can
be
combined
create
more
versatile
exquisite
functionalities.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 20, 2025
The
development
of
practical
and
selective
strategies
for
deuterium
incorporation
to
construct
deuterated
molecules,
particularly
deuterium-labeled
amino
acids,
has
become
as
a
growing
focus
basic
research,
yet
it
remains
formidable
challenge.
Herein,
we
present
bioinspired
calcium-HFIP-mediated
site-selective
reductive
deutero-amination
α-oxo-carbonyl
compounds
with
amines.
Utilizing
d2-Hantzsch
ester
the
source,
this
reaction
attains
remarkable
deuteration
efficiency
(>
99%
deuteration).
It
enables
synthesis
N-α-deuterated
acid
motifs
wide
range
functionality,
evidenced
by
over
130
examples.
method
exhibits
compatibility
diverse
substrates,
such
peptides,
drug
natural
products
bearing
different
substituents.
Moreover,
application
strategy
in
DNA-tagged
acids/peptides
been
demonstrated.
This
work
offers
an
efficient
innovative
solution
chemistry
holds
substantial
potential
organic
synthesis,
medicinal
chemistry,
chemical
biology.
JACS Au,
Journal Year:
2023,
Volume and Issue:
3(4), P. 1076 - 1088
Published: March 22, 2023
G
protein-coupled
receptors
(GPCRs)
are
the
largest
superfamily
of
human
membrane
target
proteins
for
approved
drugs.
GPCR
ligands
can
have
a
complex
array
pharmacological
activities.
Among
these
activities,
biased
agonists
potential
to
serve
as
both
chemical
probes
understand
specific
aspects
receptor
signaling
and
therapeutic
leads
with
more
specific,
desired
activity.
Challenges
exist,
however,
in
development
new
activators
due,
part,
low
throughput
traditional
screening
approaches.
DNA-encoded
libraries
(DELs)
dramatically
improve
drug
discovery
by
allowing
collective
selection,
rather
than
discrete
screening,
large
compound
libraries.
The
use
DELs
has
been
largely
limited
affinity-based
selections
against
purified
protein
targets,
which
identify
binders
only.
Herein,
we
report
split
complementation
approach
that
allows
direct
identification
DNA-linked
molecules
induce
dimerization
two
proteins.
We
used
this
selection
DEL
opioid
GPCRs
on
living
cells
small
possess
function
activation
either
β-arrestin
or
pathways.
This
was
applied
δ-,
μ-,
κ-opioid
enabled
[66,66],
selective,
G-protein-biased
agonist
(EC50
=
100
nM,
Emax
82%,
Gi
bias
factor
6.6).
should
be
generally
applicable
inducers
from
expand
utility
enrich
biochemical
function.